Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study.
Ohara M, Nagaike H, Fujikawa T, Kohata Y, Ogawa M, Omachi T, Sasajima R, Chiba H, Ara T, Sugawara A, Hiromura M, Terasaki M, Mori Y, Fukui T, Hirano T, Yokoyama H, Yamagishi SI.
Ohara M, et al. Among authors: chiba h.
Diabetes Res Clin Pract. 2021 Sep;179:108999. doi: 10.1016/j.diabres.2021.108999. Epub 2021 Aug 12.
Diabetes Res Clin Pract. 2021.
PMID: 34390762
Clinical Trial.